Clinical Lab Reimbursement Experts Discuss PAMA Pressure and Leaving Money on the Table
Attorney Danielle Tangorre and TELCOR’s Darla Wanitschke answered questions during webinar
Keeps You Up-to-Date on Federal & State Laws, Regulations, New Legislation, and Court Cases that Affect Your Diagnostic Lab or Pathology Practice
Attorney Danielle Tangorre and TELCOR’s Darla Wanitschke answered questions during webinar
However, a new memo instructs federal prosecutors to ‘avoid overreach’ when parties cooperate with authorities
CAP and AMP officials weigh in on plans to push for a legislative- or CLIA-based approach to future LDT oversight
Marginal LDT scenarios could be where the FDA focuses on next, a lawyer notes
Judge rules that the FDA has ‘no authority’ to issue its rule governing laboratory-developed tests
Put into place late last year, the new rules place more emphasis on formal and continuing education requirements
Other recent legal actions include a self-disclosure settlement and punishment for alleged improper diagnostic test add-ons
How the 2024 proposal will fare on Capitol Hill in 2025 remains to be seen, though
Changes ‘have had a significant impact on the recruitment process for laboratory directors and technical supervisors,’ recruiter says
The free online tool can set a foundation for renewed reimbursement strategies and contract negotiations with insurance carriers
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent